ニュース - Astrazeneca

名称 銘柄コード 市場 種別
Astrazeneca Plc AZN ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
30.00 0.27% 10,954.00 01:35:10
始値 安値 高値 終値 前日終値
10,934.00 10,890.00 11,012.00 10,954.00 10,924.00
この銘柄の詳細情報 »


日付 時間 ソース タイトル
2022/11/2400:30UKREGAstraZeneca PLC Director/PDMR Shareholding
2022/11/1508:24DJNADRs End Mostly Lower, Infineon and Roche Trade Actively
2022/11/1418:38ALNCNewsTOP NEWS: AstraZeneca receives three recommendations for EU..
2022/11/1416:52DJNAstraZeneca Says Enhertu Recommended for EU Approval for..
2022/11/1416:49DJNAstraZeneca's Imfinzi Plus Chemotherapy Recommended for..
2022/11/1416:44DJNAstraZeneca: Lynparza Combo Recommended in EU for Prostate..
2022/11/1416:10UKREGAstraZeneca PLC Enhertu recommended for EU approval in..
2022/11/1416:05UKREGAstraZeneca PLC Imfinzi recommended for approval in the EU..
2022/11/1416:00UKREGAstraZeneca PLC Lynparza combo recommended in the EU for..
2022/11/1118:12ALNCNewsTOP NEWS: AstraZeneca wins US FDA approval for lung cancer..
2022/11/1116:50DJNAstraZeneca's Combined Imfinzi-Imjud Lung Cancer Treatment..
2022/11/1116:00UKREGAstraZeneca PLC Imfinzi + Imjudo approved in US for lung..
2022/11/1104:53DJNTrending: AstraZeneca Boosts Guidance Amid Positive Earnings..
2022/11/1102:09DJNAstrazeneca Up Nearly 7%, On Track for Largest Percent..
2022/11/1019:48ALNCNewsTOP NEWS: AstraZeneca swings to third-quarter profit and ups..
2022/11/1017:38DJNAstraZeneca Lifts 2022 Guidance After Swing to 3Q Profit,..
2022/11/1016:58DJNAstraZeneca Lifts 2022 Guidance After Swing to 3Q Profit,..
2022/11/1016:00UKREGAstraZeneca PLC YTD and Q3 2022 Results
2022/11/0918:53ALNCNewsAstraZeneca celebrates asthma treatment recommendation by US..
2022/11/0916:00UKREGAstraZeneca PLC FDA Advisory Committee recommends PT027 in..
2022/11/0804:59ALNCNewsAstraZeneca notes positive phase III analysis for heart..
2022/11/0508:16DJNADRs End Higher, Alibaba and AstraZeneca Trade Actively
2022/11/0417:08ALNCNewsTOP NEWS: AstraZeneca's Beyfortus wins EU approval for RSV..
2022/11/0416:52DJNAstraZeneca's Nirsevimab Approved in the EU
2022/11/0416:00UKREGAstraZeneca PLC Beyfortus (nirsevimab) approved in EU
2022/11/0208:26DJNADRs End Higher, Alibaba and AstraZeneca Trade Actively
2022/11/0200:00UKREGAstraZeneca PLC Total Voting Rights
2022/11/0119:35ALNCNewsTOP NEWS: AstraZeneca's Vaxzevria wins full market..
2022/11/0116:41DJNAstraZeneca's Vaxzevria Gets Full Marketing Authorization in..
2022/10/3121:05ALNCNewsAstraZeneca to present new cardiovascular, renal drug data..
2022/10/2720:30PRNUSInvitae Announces Partnership for Real-World Data Sharing to..
2022/10/2718:58ALNCNewsAstraZeneca's Ultomiris treatment gets good results from..
2022/10/2714:11ALNCNewsStudy confirms AstraZeneca jab's higher risk of very rare..
2022/10/2617:36ALNCNewsTOP NEWS: AstraZeneca hails survival rates of breast cancer..
2022/10/2615:45DJNAstraZeneca Says Capivasertib Phase 3 Trial Met Primary..
2022/10/2615:00UKREGAstraZeneca PLC Capivasertib Phase III trial met primary..
2022/10/2607:42DJNADRs End Mostly Higher, AstraZeneca and atai Life Sciences..
2022/10/2604:35VWSterling Settles And Yields Fall As Sunak Starts First Day..
2022/10/2516:24ALNCNewsTOP NEWS: AstraZeneca's Fasenra fails to meet trial's..
2022/10/2515:47DJNAstraZeneca's Fasenra Treatment Passed One of Two Endpoints..
2022/10/2515:00UKREGAstraZeneca PLC Update on MESSINA Phase III trial
2022/10/2416:23ALNCNewsAstraZeneca treatment gets FDA approval for US liver cancer..
2022/10/2415:50DJNAstraZeneca Imjudo-Imfinzi Combination Approved by FDA to..
2022/10/2415:00UKREGAstraZeneca PLC Imfinzi + Imjudo approved in advanced liver..
2022/10/2017:06ALNCNewsTOP NEWS: AstraZeneca says Evusheld shows promise on Covid..
2022/10/1820:30GLOBEIkena Oncology Provides Research & Development Update on..
2022/10/1218:47ALNCNewsAstraZeneca to show 'exceptional' data on neuromyelitis drug..
2022/10/1215:23ALNCNewsIllumina collaborates with AstraZeneca on AI-focused..
2022/10/0407:29DJNADRs End Higher, ABB and AstraZeneca Trade Actively
今すぐ無料会員登録 し、ADVFNのストリーミングモニターで株価情報を見よう!

モニターには110もの銘柄を一度に表示することができ、またこれらは全て無料 でお使いいただけます。


ADVFNのサービスをご利用いただくには、 利用規約

P: V: D:20221128 02:17:39